Primer: Recordati (REC IM) - Aug 2026
Recordati is strategically positioned for growth, driven by its high-margin, rapidly expanding Rare Diseases business, which now accounts for...
97 Views
𝛼SK or SearchENTITY
Recordati (REC IM)
Recordati (REC IM)
27
Analysis
Health Care • Italy
Recordati is an international pharmaceutical group engaged in the research, development, manufacturing, and marketing of pharmaceuticals. The company focuses on specialty and primary care products, including treatments for cardiovascular, urological, and gastrointestinal conditions, as well as a dedicated rare disease business unit. Recordati was founded in 1926 and is headquartered in Milan, Italy.
morex